1 / 2

Global Biomarkers Market Size, Share | Report [2019-2026]

The global biomarkers market size was USD 39.10 billion in 2018 and is projected to reach USD 97.51 billion by 2026, exhibiting a CAGR of 12.1% during the forecast period.

saurabhrj
Download Presentation

Global Biomarkers Market Size, Share | Report [2019-2026]

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Title : Biomarkers Market to Reach USD 97.51 Billion by2026 Biomarkers Market to Exhibit 12.1% CAGR by2026 Description: Biomarkers Market Worth USD 97.51 Billion at 12.1% CAGR; Persistent Usage in Disease Diagnostics to Fuel Growth: Fortune BusinessInsights™ Content: The global biomarkers marketis set to gain traction from their increasing usage in a wide variety of applications, namely, drug discovery and development, safety assessment, and medicine. Besides, numerous biotech and pharmaceutical companies are persistently investing huge sums in the research and development activities. The increasing prevalence of cancer is also one of the crucial factors that would affect the market positively during the forecastperiod. The above information is given by Fortune Business Insights™ in a recent study, titled, “Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast,2019-2026.”ThestudyfurthermentionsthatthebiomarkermarketsizewasUSD 39.10 billion in 2018 and is projected to reach USD 97.51 billion by 2026, thereby exhibiting a CAGR of 12.1% during the forecastperiod. An Overview of the Impact of COVID-19 on thisMarket: The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by thepandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for thefuture. Click here to get the short-term and long-term impact of COVID-19 on this [Market]. Please visit:https://www.fortunebusinessinsights.com/biomarkers-market-102173 Drivers

  2. Increasing Demand for Personalized Medicine to AccelerateGrowth Biomarkers are increasingly used in disease diagnostics. They also play an important role in development of personalized medicine for several disease conditions. Disease diagnosis and treatment procedures possess certain limitations and because of this, the concept of personalized medicine is becoming popular nowadays. Patients suffering from immunological disorders and cancer are rapidly inclining towards customized treatment options based on their genetic and clinical features. It would propel the biomarkers market growth during the forecastperiod. RegionalAnalysis- Rising Investment by Key Players to Favor Growth in NorthAmerica The market is geographically fragmented into Asia Pacific, North America, Latin America, the MiddleEastandAfrica,andEurope.Outoftheseregions,in2018,NorthAmericaheldUSD 14.80 billionbiomarkers market revenue and is expected to grow by showcasing a high CAGR in the coming years. This is likely to occur because of the rising investments by several industry giants in the development of biomarkers. The region will be followed byEurope. Asia Pacific, on the other hand, is anticipated to grow with a higher CAGR owing to the increasing demand for disease diagnosis because of the rising incidence of cardiovascular disease and cancer. As per the Ministry of Health, approximately 203 million people are living with cardiovascular diseases in Chinaat present. It is set to upsurge by 73.0% in 2030. It would in turn, drive the growth of the market in thisregion. More Trending Topics from Fortune BusinessInsights: Europe Compression Bandages Market Share, Growth, Sales and Drivers Analysis Research Report 2026 Europe Compression Bandages Market to Witness a Healthy CAGR of 5.2%; Advent of Efficient Pressure Bandages to Provide Impetus, says Fortune BusinessInsights

More Related